Asbestos is the biggest work place killer today. Those who worked with asbestos or who are regularly in contact with someone who is at risk from asbestosis, lung cancer, mesothelioma. All these are serious breathing diseases, which is very difficult to cure. Research progress in research laboratories in different all over the USA, many drugs companies also trying to find new drugs and treatment.
One of the rare disease asbestos which makes more and more common is mesothelioma. Although known today, is almost certain that awareness of this disease to transmit worldwide because of its occurrence increases in men aged between 55 and 70. Many of these people are now lodging multiple million dollar losses against which companies they have asbestos. Those most at risk are those that were fixed in mesothelioma with fibers of asbestos dust without protection. Just a few months of exposure to asbestos can result in mesothelioma 30 years later. Latency period (the amount of time it takes for the disease to start effect) of mesothelioma is 30-50 years is one of the reasons so difficult to treat because it is difficult to cope with very early. Another reason is so mesothelioma symptoms hard to cure early symptoms are a feature of many other more common diseases such as pneumonia.
Mesothelioma symptoms include: chest pain
-Cough which has worsened over time
-Weight loss
-Shortness of breath
-And coughing up blood
-Nausea and vomiting
-Fatigue
-Vaozroth
-Pneumonia
-Swollen lymph nodes
-Loss of appetite patient will feel symptoms depending on the type of mesothelioma he received. For information about the different types of mesothelioma go to: www.1-mesothelioma.co.uk in 35 years, it is estimated at 1 million people die from asbestos-related diseases in the developed countries. Most of these people die, lung cancer mesothelioma asbestos related diseases are the two most prolific.
Source: http://gumushane.us/asbestos-mesothelioma
atherosclerosis steven tyler tropic thunder carnie wilson missing reese witherspoon pregnant billy joel
No comments:
Post a Comment